PharmaShots | Incisive News in 3 Shots

Subscribe Now

OD Designation

Albireo's A4250 Receives FDA's Orphan Drug Designation (ODD) for Biliary Atresia

Albireo's A4250 Receives FDA's Orphan Drug Designation (ODD) for Biliary Atresia

January 23, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us